Cytomegalovirus esophagitis in an adolescent with human immunodeficiency virus infection: a clinical case

T.P. Borysova, L.P. Badogina, Z.S. Allahverdieva, L.D. Zabolotnia, S.О. Shсhudro


Gastrointestinal disorder is one of the main elements in a number of pathological changes characteristic of human immunodeficiency virus (HIV) infection in children. Such lesion can be caused by direct impact of the virus on the gastrointestinal tract, opportunistic infections, prolonged use of drugs (antibiotics, antivirals, antifungals).With the progression of HIV-infection, the risk of pathology of the digestive system increases. Among opportunistic diseases, a special attention should be paid to cytomegalovirus (CMV) infection, in which all the organs and systems of the child are involved in the pathological process, including the gastrointestinal tract. Esophagitis is the second most common gastrointestinal disorder after colitis in such patients. With CMV esophagitis in HIV-infected children, the clinical symptoms are nonspecific. Endoscopic examination is quite informative. Available literature contains descriptions of esophagitis in children with HIV-infection, but the focus was made on damage to the esophagus caused by fungi. The presented clinical case demonstrates the development of CMV esophagitis in an adolescent with HIV-infection. Poor patient’s adherence to therapy allowed the disease to develop naturally, with a progressive decline in the immune status, the occurrence of an opportunistic CMV infection with a predominant lesion of the esophagus and severe CMV esophagitis. The development of this complication did not make it possible to correct antiretroviral therapy. This clinical case illustrates the progressive course of HIV-infection with the development of severe CMV esophagitis in an adolescent against the background of poor adherence to antiretroviral therapy.


human immunodeficiency virus infection; children; immunodeficiency; gastrointestinal tract; cytomegalovirus infection; esophagitis


Ministry of Нealth of Ukraine. Order on February 24, 2015 № 92. On Adoption and Implementation of Medical and Technological Documents for Standardizing Medical Care for HIV-infected Children. Available from: Accessed: February 24, 2015. (in Ukranian).

Khasanova GM, Urunova DM, Akhmedzhanova ZI, Giyasova GM, Chernikova AA, Khasanova AN. Defeat of the gastrointestinal tract in hiv infection. Tihookeanskij medicinskij žurnal. 2019;(77):24-28. doi:10.17238/PmJ1609-1175.2019.3.24-28. (in Russian).

Timchenko VN, Arkhipova YuA. Gastrointestinal manifestations of pediatric HIV infection. Detskie Infektsii. 2010;(3):22-26. (in Russian).

Wang HW, Kuo CJ, Lin WR, et al. The clinical characteristics and manifestations of cytomegalovirus esophagitis. Dis Esophagus. 2016;29(4):392-399. doi:10.1111/dote.12340.

Gori A, Tincati C, Rizzardini G, et al. Early impairment of gut function and gut flora supporting a role for alteration of gastrointestinal mucosa in human immunodeficiency virus pathogenesis. J Clin Microbiol. 2008;46(2):757-758. doi:10.1128/JCM.01729-07.

Bordea MA, Pîrvan A, Gheban D, et al. Infectious Esophagitis in Romanian Children: From Etiology and Risk Factors to Clinical Characteristics and Endoscopic Features. J Clin Med. 2020;9(4):939. doi:10.3390/jcm9040939.

Nyankovskyy SL, Horodilovska MІ, Іvantsіv VA, Boyko OІ. Differential diagnosis of esophagitis in schoolchildren. Zdorovʹe rebenka. 2016;(76):56-61. doi:10.22141/2224-0551.8.76.2016.90825. (in Ukranian).

Rosołowski M, Kierzkiewicz M. Etiology, diagnosis and treatment of infectious esophagitis. Prz Gastroenterol. 2013;8(6):333-337. doi:10.5114/pg.2013.39914.

Hoversten P, Kamboj AK, Wu TT, Katzka DA. Risk Factors, Endoscopic Features, and Clinical Outcomes of Cytomegalovirus Esophagitis Based on a 10-year Analysis at a Single Center. Clin Gastroenterol Hepatol. 2020;18(3):736-738. doi:10.1016/j.cgh.2019.04.066.

Machadoa NC, Carvalhoa MA, Ortolanb EVP, Rodriguesc MAM. Severe Distal Cytomegalovirus Esophagitis With Aerodigestive Symptoms in an Immunocompetent Infant. Int J Clin Pediatr. 2013;2(1):40-43. doi:10.4021/ijcp78w.

Madsen M, Nielsen H. Cytomegalovirus esophagitis in a child with human immunodeficiency virus-1 infection presenting as fever of unknown origin and stunted growth. Eur J Pediatr. 2006;165(9):665-666. doi:10.1007/s00431-006-0144-x.

Bobak DA. Gastrointestinal Infections Caused by Cytomegalovirus. Curr Infect Dis Rep. 2003;5(2):101-107. doi:10.1007/s11908-003-0044-4.

Apont J, Vera JD, Chaar A, Martin D, Yency F. Cytomegalovirus Infection (CMV) and Human Immunodeficiency Virus: Diagnostic and Therapeutic Challenges in Virology. Arch Microbiol Immunology. 2018;(2):018-035. doi:10.26502/ami.936 50019.

Jung KH, Choi J, Gong EJ, et al. Can endoscopists differentiate cytomegalovirus esophagitis from herpes simplex virus esophagitis based on gross endoscopic findings? Medicine (Baltimore). 2019;98(23):e15845. doi:10.1097/MD.0000000000015845.

Sheth A, Boktor M, Diamond K, Lavu K, Sangster G. Complete esophageal obliteration secondary to cytomegalovirus in AIDS patient. Dis Esophagus. 2010;23(6):E32-E34. doi:10.1111/j.1442-2050.2010.01095.x.

Diamond GH, Mascarenhas MR. Pediatric Esophagitis. Available from: Accessed: September 20, 2017.

Marques S, Carmo J, Pinto D, Bispo M, Ramos S, Chagas C. Cytomegalovirus Disease of the Upper Gastrointestinal Tract: A 10-Year Retrospective Study. GE Port J Gastroenterol. 2017;24(6):262-268. doi:10.1159/000479232.

Hanisch BR, Belani K. CMV esophagitis as a cause of failure to thrive. Minn Med. 2014;97(9):50.

Velocci V, Piper MH. Cytomegalovirus Esophagitis Overview of Cytomegalovirus. Available from: Accessed: April 01, 2019.

Lim DS, Lee TH, Jin SY, Lee JS. Cytomegalovirus esophagitis in an immunocompetent patient: case report. Turk J Gastroenterol. 2014;25(5):571-574. doi:10.5152/tjg.2014.4073.

Cooke ML, Goddard EA, Brown RA. Endoscopy findings in HIV-infected children from sub-Saharan Africa. J Trop Pediatr. 2009;55(4):238-243. doi:10.1093/tropej/fmn114.

Nachega JB, Hislop M, Dowdy DW, Chaisson RE, Regensberg L, Maartens G. Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes. Ann Intern Med. 2007;146(8):564-573. doi:10.7326/0003-4819-146-8-200704170-00007.

Reddi A, Leeper SC. Antiretroviral therapy adherence in children: outcomes from Africa. AIDS. 2008;22(7):906-907. doi:10.1097/QAD.0b013e3282f706ba.

Ministry of Нealth of Ukraine. Order on June 05, 2019 № 1292. On Adoption of the New Clinical Protocol for the Use of Antiretroviral Drugs for the Treatment and Prevention of HIV-infection. Available from: Accessed: June 05, 2019. (in Ukranian).

Martin S, Elliott-DeSorbo DK, Wolters PL, et al. Patient, caregiver and regimen characteristics associated with adherence to highly active antiretroviral therapy among HIV-infected children and adolescents. Pediatr Infect Dis J. 2007;26(1):61-67. doi:10.1097/01.inf.0000250625.80340.48.

Kim SH, Gerver SM, Fidler S, Ward H. Adherence to antiretroviral therapy in adolescents living with HIV: systematic review and meta-analysis. AIDS. 2014;28(13):1945-1956. doi:10.1097/QAD.0000000000000316.

Copyright (c) 2020 CHILD`S HEALTH

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.


© Publishing House Zaslavsky, 1997-2020


   Seo анализ сайта